期刊文献+

血浆晚期糖基化终末产物水平对肠梗阻术后病情判断的意义 被引量:5

Significance of Plasma Level of Advanced Glycation End Products in Evaluation of Patients' Condition After Operations for Intestinal Obstruction
下载PDF
导出
摘要 目的探讨血浆晚期糖基化终末产物(AGEs)水平变化对肠梗阻术后患者病情评估的临床意义。方法选取2010年5月—2014年2月辽宁医学院附属第一医院胃肠外科收治的肠梗阻患者376例,其中术后未出现并发症者324例,为对照组;出现并发症者52例,为试验组,分别为感染11例,肠道功能障碍16例,血糖紊乱8例,吻合口破裂及瘘5例,急性呼吸窘迫综合征(ARDS)8例,肠系膜动脉栓塞4例。分别无菌采集患者术后第1、3、5、7、14天静脉血3 ml,采用ELISA法检测血浆AGEs水平。结果两组术后不同时间血浆AGEs水平比较,差异有统计学意义(P<0.05)。组间比较结果显示:术后第1、14天,两组血浆AGEs水平比较,差异无统计学意义(P>0.05);术后第3、5、7天,试验组血浆AGEs水平高于对照组(P<0.05)。组内比较结果显示,试验组术后第3天血浆AGEs水平高于术后第1天(P<0.05)。不同肠梗阻并发症患者术后不同时间血浆AGEs水平比较,差异有统计学意义(P<0.05)。组间比较结果显示:术后第3、5、7天,不同肠梗阻并发症患者血浆AGEs水平比较,差异有统计学意义(P<0.05),其中感染患者血浆AGEs水平均高于其他并发症类型者(P<0.05)。组内比较结果显示,不同肠梗阻并发症类型患者术后第3天血浆AGEs水平均高于术后第1天(P<0.05)。结论监测肠梗阻术后患者血浆AGEs水平变化有助于判断患者术后是否出现并发症,并且当患者血浆出现高浓度AGEs时,应当高度怀疑存在局部或全身感染。 Objective To investigate the significance of the plasma level of advanced glycation end products( AGEs)in the evaluation of patients' condition after operations for intestinal obstruction. Methods A total of 376 patients with intestinal obstruction who were admitted into the Department of Gastroenterological Surgery of First Affiliated Hospital of Liaoning Medical University from May 2010 to February 2014 were enrolled. 324 patients without postoperative complications were assigned into the control group,and patients with postoperative complications were assigned into the trial group( n = 52),in which 11 patients had infection,16 had intestinal dysfunction,8 had dysglycemia,5 had anastomotic rupture and fistula,8 had acute respiratory distress syndrome( ARDS) and 4 had mesenteric artery embolization. On day 1,3,5,7 and 14 after operations,3 ml of sterile blood was collected from each patient and the plasma level of AGEs was tested using ELISA method. Results Two groups were significantly different in the plasma level of AGEs at different time points( P〈0. 05). The comparison between two groups showed that two groups were not significantly different in the plasma level of AGEs on day 1 and 14( P〉0. 05) and the trial group was higher than the control group in the plasma level of AGEs on day 3,5 and 7( P〈0. 05). The comparison within the trial group showed that the plasma level of AGEs on day 3 was higher than that on day 1( P〈0. 05). Patients with different complications were significantly different in the plasma level of AGEs at different time points after operations( P〈0. 05). On day 3,5 and 7, patients with different complications were significantly different in the plasma level of AGEs( P〈0. 05).Patients with infection were all higher than patients with other complications in the plasma level of AGEs( P〈0. 05). For allpatients with complications,the plasma level of AGEs on day 3 was higher than that on day 1( P〈0. 05). Conclusion Postoperative monito
作者 刘艳辉
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第11期1280-1283,共4页 Chinese General Practice
关键词 糖基化终产物 高级 肠梗阻术后 术后并发症 Glycation end products advanced After operations for intestinal obstruction postoperative complication
  • 相关文献

参考文献19

  • 1雷超,胡占升.慢性阻塞性肺疾病患者血浆晚期糖基化终末产物和可溶性糖基化终末产物受体浓度变化及其临床意义[J].中国全科医学,2014,17(8):875-879. 被引量:9
  • 2Christaki E, Lazaridis N, Opal SM. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis? [J]. Curr Opin Infect Dis, 2012, 25 (3) : 304 -311. 被引量:1
  • 3Gu WJ, Wan YD, Tie HT, et al. Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre - existing diabetes: a meta - analysis [ J ]. PloS One, 2014, 9 (2) : e90426. 被引量:1
  • 4Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions [ J ]. Neurogastroenterol Motil, 2014,26 ( 5 ) : 611 - 624. 被引量:1
  • 5Chang PC, Tsai SC, Jheng YH, et al. Soft - tissue wound healing by anti - advanced glycation end - products agents [ J ]. J Dent Res, 2014, 93 (4): 388-393. 被引量:1
  • 6Menazza S, Canton M, Sorato E, et al. Old and new biomarkers of oxidative stress in heart failure [ J ]. Drug Discovery Today: Therapeutic Strategies, 2012, 9 (4): e189-e198. 被引量:1
  • 7Jackson PG, Raiji M. Evaluation and management of intestinal obstruction [J]. Am Fam Physician, 2011, 83 (2) : 159 -165. 被引量:1
  • 8Friggeri A, Banerjee S, Biswas S, et al. Participation of the receptor for advanced glycation end products in efferocytosis [ J ]. J Immunol, 2011, 186 (11): 6191-6198. 被引量:1
  • 9Vlassara H, Uribarri J. Advanced glyeation end products (AGE) and diabetes: cause, effect, or both? [J]. Curt Diab Rep, 2014, 14 (1): 453. 被引量:1
  • 10Shi L, Chen H, Yu X, et al. Advanced glycation end products delay corneal epithelial wound healing through reactive oxygen species generation [ J ]. Mol Cell Biochem, 2013, 383 (1/2): 253 - 259. 被引量:1

二级参考文献48

  • 1王瑞良,苏青.RAGE及其配体的临床意义研究进展[J].国际内分泌代谢杂志,2006,26(3):160-162. 被引量:23
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3Forbes JM, Thallas V, Thomas MC, et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J, 2003,17 : 1762-1764. 被引量:1
  • 4Candido R, Forbes JM, Thomas MC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes: Circ Res, 2003,92:785-792. 被引量:1
  • 5Haslbeck KM, Schleieher E, Bierhaus A, et al. The AGEVRAGE/NF-kappaB pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes,2005,113 : 288-291. 被引量:1
  • 6Prevost G, Fajardy I, Besmond C, et al. Polymorphisms of the neceptor of advanced glycation end products (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab, 2005, 31 : 35-39. 被引量:1
  • 7Kankova K, Stejskalova A, Hertlova M, et al. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant, 2005,20: 1093-1102. 被引量:1
  • 8Yamamoto Y, Kato I, Doi T, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest,2001,108:261-268. 被引量:1
  • 9Wendt TM, Tanji N, Guo J, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol, 2003,162:1123-1137. 被引量:1
  • 10Yan SF, Ramasamy R, Naka Y, et al. Glycation,inflammation,and RAGE:a scaffold for the macrovascular complications of diabetes and beyond. Circ Res, 2003,93 : 1159-1169. 被引量:1

共引文献34

同被引文献39

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部